ESSA Pharma Inc (NASDAQ:EPIX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past) | Director · Since at least Oct 1, 2020 |
| Marella Thorell Other companies: Carisma Therapeutics, Inc. (Director · Since at least Jun 30, 2024); Seres Therapeutics, Inc. (EVP, Chief Financial Officer · Since at least Mar 25, 2024); Evelo Biosciences, Inc. (Chief Financial Officer · Jul 13, 2022 – Nov 7, 2023 · Past); Centessa Pharmaceuticals PLC (Chief Accounting Officer · May 27, 2021 – Mar 21, 2022 · Past); GRI Bio, Inc. (Director · Feb 9, 2021 – Dec 13, 2022 · Past) | Director · Since at least Oct 1, 2020 |
| Scott Requadt Other companies: Tourmaline Bio Inc. (Chief Executive Officer, Director · May 6, 2021 – Feb 1, 2023 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); VBI Vaccines Inc. (Director · Dec 31, 2016 – Jan 31, 2019 · Past) | Director · Since at least Oct 1, 2020 |
| Lauren Merendino Other companies: Day One Biopharmaceuticals Inc (Chief Commercial Officer · Since at least Feb 26, 2025); Myovant Sciences Ltd (Chief Commercial Officer · Apr 5, 2021 – Mar 10, 2023 · Past) | Director · Jun 6, 2023 – Mar 25, 2024 · Past |
| Philip W Kantoff Other companies: Context Therapeutics Inc. (Director · Since at least Oct 19, 2021) | Director · Sep 13, 2022 – Mar 25, 2024 · Past |
| Richard Glickman Other companies: enGene Therapeutics Inc. (Director · Since at least Oct 31, 2023) | Director · Since at least Oct 1, 2020 |
| David S Wood | Chief Financial Officer · Since at least Oct 1, 2020 |
| Gary Sollis | Director · Oct 1, 2020 – Mar 25, 2024 · Past |
| John Alexander Martin | Director · Since at least Oct 1, 2020 |